Long-term risk of recurrence in surgically treated renal cell carcinoma: A post Hoc analysis of the eastern cooperative oncology group—American college of radiology imaging network E2805 trial cohort

European Urology Jan 23, 2020

Jamil ML, Keeley J, Sood A, et al. - Experts intended to examine the long-term risk of recurrence in surgically treated renal cell carcinoma (RCC) in order to ascertain the utility of long-term surveillance. They conducted a post hoc analysis of individuals within the Eastern Cooperative Oncology Group—American College of Radiology Imaging Network E2805. A total of 1,943 individuals were included in this study. In order to dynamically assess recurrence through the use of a conditional survival model, the measured 36-mo cumulative incidence of recurrence at set intervals following surgery. The results suggested that follow-up for surgically resected localized renal cell carcinoma should be conducted beyond 5 yr, for the rates of recurrence remain significant beyond this 5 yr endpoint.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen